Version 1
: Received: 18 March 2024 / Approved: 19 March 2024 / Online: 19 March 2024 (05:13:05 CET)
How to cite:
Strickland, I.; Oakley, D.S.; Parievsky, A. Improved Brain Function with Deep Spectrum Biotherapeutics. Preprints2024, 2024031073. https://doi.org/10.20944/preprints202403.1073.v1
Strickland, I.; Oakley, D.S.; Parievsky, A. Improved Brain Function with Deep Spectrum Biotherapeutics. Preprints 2024, 2024031073. https://doi.org/10.20944/preprints202403.1073.v1
Strickland, I.; Oakley, D.S.; Parievsky, A. Improved Brain Function with Deep Spectrum Biotherapeutics. Preprints2024, 2024031073. https://doi.org/10.20944/preprints202403.1073.v1
APA Style
Strickland, I., Oakley, D.S., & Parievsky, A. (2024). Improved Brain Function with Deep Spectrum Biotherapeutics. Preprints. https://doi.org/10.20944/preprints202403.1073.v1
Chicago/Turabian Style
Strickland, I., David S Oakley and Anna Parievsky. 2024 "Improved Brain Function with Deep Spectrum Biotherapeutics" Preprints. https://doi.org/10.20944/preprints202403.1073.v1
Abstract
In this case series, we examine the impact of the Titan-iR Pro® deep spectrum biotherapeutic device on brain function in healthy individuals. Here we present 15 participants, aged 26-68 years, who enrolled in this open-label study, designed to assess the effect of a single 15-minute course of deep spectrum biotherapy on brain function. Although symptom-free upon enrollment, participants had diverse medical histories with some displaying early signs of cognitive decline. As part of the evaluation, all participants engaged in electroencephalogram (EEG) recording sessions that focused on assessing event-related potential (ERP) evaluations, including audio P300 amplitudes and latencies (speeds), neurocognitive testing, and physical reaction times. Following the Titan-iR Pro intervention an improvement in EEG-based cognitive markers was observed. These results underscore the importance of further investigation into the potential of advanced and deep spectrum photobiomodulation in the prevention and treatment of cognitive decline and other neurological disorders.
Keywords
Electroencephalogram (EEG); Event Related Potential (ERP); Advanced & Deep Biotherapeutics; Photobiomodulation (PBM); Mild Cognitive Impairment (MCI)
Subject
Medicine and Pharmacology, Neuroscience and Neurology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
